The U.S. Preventative Services Task Force released an updated draft recommendation on HIV screening yesterday, with a recommendation for general screening of the 15 - 65 year old population. The recommendation is a significant expansion of it's previous position, which suggested screening only those at risk for HIV. The release gave a boost to Orasure (OSUR +1.4%) today, whose OraQuick Advance is the only FDA-approved rapid point-of-care test that can detect antibodies to both HIV-1 and HIV-2 in just 20 minutes.
The U.S. Preventative Services Task Force released an updated draft recommendation on HIV...
From other sites
Video at CNBC.com (May 19, 2015)
at CNBC.com (Nov 19, 2012)
at CNBC.com (Oct 23, 2012)
at CNBC.com (Oct 8, 2012)
at CNBC.com (Jul 13, 2012)
ETF Screener: Search and filter by asset class, strategy, theme, performance, yield, and much more
ETF Performance: View ETF performance across key asset classes and investing themes
ETF Investing Guide: Learn how to build and manage a well-diversified, low cost ETF portfolio
ETF Selector: An explanation of how to select and use ETFs